Abstract | OBJECTIVE: METHODS: We retrospectively compared ocular herpes simplex virus recurrence in 2 groups of patients. In group 1, patients used oral acyclovir for at least 12 months and then discontinued the treatment. In group 2, patients received the treatment for at least 18 months. We compared recurrences when both groups were using acyclovir (period 1) and when only group 2 was receiving the drug (period 2). Statistical analysis was performed with the t test, chi2 test, and Kaplan-Meier method. RESULTS: Group 1 had 18 patients and a mean +/- SD follow-up of 45.2 +/- 22.2 months. Group 2 had 22 patients and a mean +/- SD follow-up of 42.4 +/- 30.2 months. Six patients (33%) in group 1 and 4 patients (18%) in group 2 had recurrence in period 1 (P =.3). In period 2, 14 patients (78%) in group 1 and 8 patients (36%) in group 2 had recurrence (P =.01). Mean +/- SD recurrence-free survival in period 2 was 15.3 +/- 5.5 months in group 1 and 37.3 +/- 6.3 months in group 2 (P =.001). CONCLUSIONS:
|
Authors | Uchoandro B C Uchoa, Renata A Rezende, Maria A Carrasco, Christopher J Rapuano, Peter R Laibson, Elisabeth J Cohen |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 121
Issue 12
Pg. 1702-4
(Dec 2003)
ISSN: 0003-9950 [Print] United States |
PMID | 14662588
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Acyclovir
|
Topics |
- Acyclovir
(therapeutic use)
- Administration, Oral
- Adult
- Antiviral Agents
(therapeutic use)
- Blepharitis
(prevention & control, virology)
- Conjunctivitis, Viral
(prevention & control, virology)
- Disease-Free Survival
- Female
- Follow-Up Studies
- Herpes Simplex
(prevention & control)
- Humans
- Iritis
(prevention & control, virology)
- Keratitis, Herpetic
(prevention & control)
- Male
- Middle Aged
- Retrospective Studies
- Secondary Prevention
|